Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Alzheimers Dement. 2023 Sep 10;19(Suppl 9):S98–S114. doi: 10.1002/alz.13453

FIGURE 1.

FIGURE 1

Study flow and amyloid-PET screening. (A) Flowchart of patient selection and cohort assignment. (B) PET-only quantification performed for amyloid-PET screening (dashed line indicate the SUVRPET-only threshold of 1.18). CI, cognitively impaired; CN, cognitively normal; EOAD, early-onset Alzheimer’s disease; EOnonAD, early-onset non-Alzheimer’s disease; FBB, 18F-Florbetaben; FTP, 18F-Flortaucipir; PET, positron emission tomography